Effect of Recombinant FVIII in Healthy Male Subjects Treated With TB-402
NCT00612417
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Administration of recombinant FVIII/placebo in healthy male subjects treated with TB-402
Sponsor
ThromboGenics
Collaborators
[object Object]